Health Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review (SLR) and Meta-Analysis

被引:0
|
作者
Banerjee, Rahul [1 ]
Hasegawa, Ken [2 ]
Itani, Taha [2 ]
Giordana, Monique [2 ]
Granados, Enrique [2 ]
Rosado, Margrit B. [3 ]
Chan, Rebecca J. [3 ]
Kostic, Ana [3 ]
Kanters, Steve [4 ]
Zoratti, Michael J. [4 ]
Leleu, Xavier [5 ]
机构
[1] Fred Hutchinson Canc Ctr, Seattle, WA USA
[2] Kite, Gilead Co, Santa Monica, CA USA
[3] Arcellx Inc, Redwood City, CA USA
[4] RainCity Analyt, Vancouver, BC, Canada
[5] CHU Poitiers, Poitiers, France
关键词
D O I
10.1182/blood-2024-203741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4721 / 4722
页数:2
相关论文
共 50 条
  • [1] SYSTEMATIC LITERATURE REVIEW (SLR) OF EVIDENCE ON THE HUMANISTIC BURDEN OF RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Anna, F.
    Kwon, C. S.
    Kim, M. E.
    Neuhof, A.
    Bell, T.
    Mamolo, C.
    VALUE IN HEALTH, 2020, 23 : S476 - S476
  • [2] A SYSTEMATIC LITERATURE REVIEW (SLR) OF HEALTH STATE UTILITY VALUES (HSUVS) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Anna, F.
    Kim, M. E.
    Kwon, C. S.
    Bell, T.
    Mamolo, C.
    VALUE IN HEALTH, 2020, 23 : S476 - S476
  • [3] Health-related quality of life outcomes in relapsed and/or refractory multiple myeloma: a systematic review
    Sparano, Francesco
    Cavo, Michele
    Niscola, Pasquale
    Efficace, Fabio
    QUALITY OF LIFE RESEARCH, 2016, 25 : 123 - 124
  • [4] HEALTH RELATED QUALITY OF LIFE (HRQOL) REVIEW IN PATIENTS WITH OVARIAN CANCER: A SYSTEMATIC LITERATURE REVIEW (SLR)
    Azmi, S.
    Barnes, G.
    Xuan, D.
    Tang, B.
    VALUE IN HEALTH, 2021, 24 : S61 - S61
  • [5] Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients
    van Beurden-Tan, Chrissy H. Y.
    Franken, Margreet
    Blommestein, Hedwig
    Uyl-de Groot, Carin
    Sonneveld, Pieter
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E144 - E144
  • [6] Systematic Literature Review and Network Meta-Analysis of Treatment Outcomes in Relapsed and/or Refractory Multiple Myeloma
    van Beurden-Tan, Chrissy H. Y.
    Franken, Margreet G.
    Blommestein, Hedwig M.
    Uyl-de Groot, Carin A.
    Sonneveld, Pieter
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (12) : 1312 - +
  • [7] Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients
    Van Beurden-Tan, Chrissy H. Y.
    Franken, Margreet
    Blommestein, Hedwig
    Uyl-De Groot, Carin A.
    Sonneveld, Pieter
    BLOOD, 2016, 128 (22)
  • [8] Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis
    Chen, Runzhe
    Wang, Yujie
    Luan, Chengxin
    Gao, Chong
    Zhang, Xiaoping
    Chen, Baoan
    JOURNAL OF CANCER, 2017, 8 (10): : 1801 - 1808
  • [9] SLR OF ECONOMIC EVALUATION FOR TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN UK
    Mehta, J.
    Harrison, O.
    Barwood, C.
    Ubi, S.
    Bertranou, E.
    Bouhlabel, F.
    Low, E.
    Shah, A.
    Korde, R.
    Shah, J.
    Gaugris, S.
    VALUE IN HEALTH, 2020, 23 : S51 - S52
  • [10] HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) - Health-Related Quality of Life (HRQoL) Analysis
    Oriol, Albert
    Richardson, Paul G.
    Mateos, Maria-Victoria
    Larocca, Alessandra
    Creixenti, Joan Blade
    Cavo, Michele
    Rodriguez-Otero, Paula
    Norkin, Maxim
    Nadeem, Omar
    Hiemenz, John W.
    Hassoun, Hani
    Touzeau, Cyrille
    Amor, Adrian Alegre
    Paner, Agne
    Maisel, Christopher
    Mazumder, Amitabha
    Raptis, Anastasios
    Puig, Noemi
    Strang, Peter
    Sandberg, Anna
    Jaques, Christian
    Thuresson, Marcus
    Orre, Marie
    Leleu, Xavier
    BLOOD, 2020, 136